BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the appointment of industry veteran, Theron (Ted) Odlaug, Ph.D. as a new independent director to its Board. Dr. Odlaug will also serve as a member of Unigene’s Compensation and Nominating and Governance Committees.
